How THC and CBD affect the brain's reward system, and what that means for psychosis

THC appears to disrupt reward-related brain regions in ways that correlate with psychotic symptoms, while CBD may push those same regions in the opposite direction.

Gunasekera, Brandon et al.·Psychopharmacology·2022·Moderate EvidenceNarrative Review
RTHC-03891Narrative ReviewModerate Evidence2022RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Narrative Review
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

THC modulated activity in the striatum, midbrain, insula, and anterior cingulate during reward processing, with some effects correlating with the severity of THC-induced psychotic symptoms. CBD appeared to modulate the same reward and salience regions in the opposite direction.

Key Numbers

People with psychosis show increased striatal presynaptic dopamine synthesis and release. Cannabis users generally show impaired presynaptic dopaminergic function, though acute THC challenges produced only modest effects on striatal dopamine.

How They Did This

Narrative review combining preclinical and human neuroimaging evidence. A systematic search identified acute cannabinoid drug-challenge studies using neuroimaging in healthy subjects and people with psychosis.

Why This Research Matters

Both psychosis and THC use involve altered dopamine signaling in the striatum. Understanding whether cannabinoid effects on reward processing underlie psychotic symptoms could clarify why some cannabis users develop psychosis while others do not.

The Bigger Picture

The overlap between cannabinoid effects on reward circuitry and the neurobiology of psychosis raises the question of whether endocannabinoid dysfunction and reward processing abnormalities are mechanistically linked in psychotic disorders.

What This Study Doesn't Tell Us

Narrative review rather than systematic meta-analysis. Acute THC challenge studies may not reflect chronic cannabis use. The relationship between reward processing changes and psychotomimetic effects remains correlational.

Questions This Raises

  • ?Does CBD's opposing effect on reward regions explain its potential antipsychotic properties?
  • ?Could individual differences in reward circuitry predict psychosis risk from cannabis use?

Trust & Context

Key Stat:
THC and CBD modulated the same reward and salience brain regions in opposite directions
Evidence Grade:
Narrative review synthesizing preclinical and human imaging data with some systematic search elements.
Study Age:
Published in 2022, reviewing literature up to that point.
Original Title:
Cannabinoids, reward processing, and psychosis.
Published In:
Psychopharmacology, 239(5), 1157-1177 (2022)
Database ID:
RTHC-03891

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research without a strict systematic method.

What do these levels mean? →

Frequently Asked Questions

Does THC cause psychosis through the reward system?

The review found overlap between THC's effects on reward circuitry and the neurobiology of psychosis, but whether reward processing changes actually cause psychotic symptoms remains unclear.

Can CBD counteract THC's effects on the brain?

Imaging evidence suggests CBD modulates reward and salience regions in the opposite direction to THC, though the clinical significance of this opposition needs further study.

Read More on RethinkTHC

Cite This Study

RTHC-03891·https://rethinkthc.com/research/RTHC-03891

APA

Gunasekera, Brandon; Diederen, Kelly; Bhattacharyya, Sagnik. (2022). Cannabinoids, reward processing, and psychosis.. Psychopharmacology, 239(5), 1157-1177. https://doi.org/10.1007/s00213-021-05801-2

MLA

Gunasekera, Brandon, et al. "Cannabinoids, reward processing, and psychosis.." Psychopharmacology, 2022. https://doi.org/10.1007/s00213-021-05801-2

RethinkTHC

RethinkTHC Research Database. "Cannabinoids, reward processing, and psychosis." RTHC-03891. Retrieved from https://rethinkthc.com/research/gunasekera-2022-cannabinoids-reward-processing-and

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.